- Total Do-It-Yourself Portfolios with AFFX:
- A4 Quality Returns
- Paul Portfolio 2
- Jerry Williams Portfolio 1
- dr gayle
- xarex Portfolio 1
- marks2ndpricks
- check
- blackoak Portfolio 1
- barking dog
- gadfly Portfolio 1
- dlist
- nmgbriones Portfolio 1
- techjunkie
- jmesick Portfolio 1
- Vessel of Love
- gkholdi
- high risk micro cap
- SUPRATRADE 3007071748
- japaulo Portfolio 1
- sdparsons Portfolio 1
- YashRaj
- JSerota Portfolio 1
- oyarsa Portfolio 1
- PART 5 JPMorgan 26th Annual Healthcare Conf 1/9/08..3rd Day Reporting Companies..Nymph Take
- Time to Look for Stocks Below $10
- Fast Money's First 100 Days Trade
- show more
- 52
- jay pazos Portfolio 1
- VM Gem's
- gary Portfolio 1
- ERB_Portfolio
- Andrew M Cutler Portfolio 1
- Macer
- Silas Smith Portfolio 1
- ringo Portfolio 1
- bayside 3
- Pi - 3.1416
- otter101 Portfolio 1
- SUPRATRADE PANTERA II
- The Temple Portfolio
- kcar Portfolio 1
- stewarg66 local portfolio ii
- Seths Growth Fund
- cgerdes87 Portfolio 1
- dmoder Portfolio 1
- scg427 Portfolio 1
- imnotcatholic18 Portfolio 1
- BENITRANS IC
- BREAKOUTS2008
- StockpickrOne
- LivingstonGroup Portfolio - Healthcare
- Barron's Cheap Losers For A Market Revival
- Last Day of the JPMorgan Healtcare Conf.
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
Date:01 10 09 |
|
10 |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:11 12 08 |
Parmentier explained that Democrats will pump a ton of money into Medicaid. He told viewers to look at Molina Healthcare(MOH), Amerigroup(AGP), Centene(CNC), Affymetrix(AFFX) and UnitedHealth Group(UNH). |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:10 18 08 |
As for Affymetrix, the Santa Clara, Calif., company is also cutting costs after announcing Tuesday that it missed September-quarter sales forecasts -- its second quarterly whiff. Shares of the genomics supplier now go for less than half of the company's $9 per share in cash, and less than twice free cash flow. Yet Affymetrix pioneered the manufacture of the "gene chips" used by medical researchers to measure activity levels of genes implicated in diseases and their treatments. Its shares now offer a cheap bet on the adoption of gene chips by doctors seeking to predict which drugs work best on a patient's cancer. |
|
Not yet rated
Rate now:
|
|
By:stockerblog |
Date:07 28 08 |
PE of 13 and a PEG of 0.67. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Affymetrix (AFFX) was downgraded to Underperform, Bear Stearns said. Estimates also cut, as the company warned of lower sales. $12 price target. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Affymetrix (AFFX) upgraded to Buy rating from Neutral at UBS. Price target lifts to $33 from $29 and 2008 eps estimates dip to $0.40 from $0.50. |
|
Not yet rated
Rate now:
|
|
By:memocobo |
Date:10 16 07 |
CNBC...............26.75................1.18%............10/16/07 |
|
Not yet rated
Rate now:
|
|
By:supratrade |
Date:07 16 07 |
Target: $34.00 |
|
Not yet rated
Rate now:
|
|
By:joeyzz2 |
Date:06 05 07 |
Growth of Genetics and testing equipment. |
|
Not yet rated
Rate now:
|
|
By:temple |
Date:05 09 07 |
Very curious as to their growth |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
By:dpincus216 |
Date:04 26 08 |
the leaders of the field have let it all run away |
|
Not yet rated
Rate now:
|
|








